Related Experiment Videos
Fluorogenic assay for beta-glucuronidase using microchip-based capillary electrophoresis
1Department of Chemistry, University of Cincinnati, OH 45221-0172, USA.
Summary
Microchip capillary electrophoresis (CE) offers a novel approach for drug screening by analyzing enzyme activity. This method successfully determined enzyme kinetics and inhibition, demonstrating its potential for high-throughput screening applications.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Biotechnology
Background:
- Enzyme assays are crucial for drug discovery and development.
- Conventional methods can be time-consuming and require significant sample volumes.
- Microchip capillary electrophoresis (CE) presents a miniaturized and efficient alternative for biochemical analyses.
Purpose of the Study:
- To evaluate the utility of microchip CE for combinatorial drug screening using a model enzyme assay.
- To determine kinetic parameters and inhibitor effects of beta-glucuronidase.
- To compare microchip CE performance with conventional CE methods.
Main Methods:
- Utilized microchip CE to separate fluorescein mono-beta-D-glucuronide (FMG) and its hydrolysis product, fluorescein.
- Monitored fluorescein production to assess beta-glucuronidase activity.
- Performed Michaelis-Menten enzyme kinetics and inhibitor assays (IC50 determination) using microchip CE.
Main Results:
- Successfully separated FMG and fluorescein using microchip CE.
- Determined the Michaelis constant (Km) for beta-glucuronidase with FMG to be 18 microM, a novel finding.
- Quantified the inhibitory effect of D-saccharic acid-1,4-lactone (SL) with an IC50 value of 3 microM.
Conclusions:
- Microchip CE is a viable and sensitive platform for enzyme kinetic studies and drug screening.
- The method provides accurate and reproducible results comparable to conventional CE.
- This technology holds promise for high-throughput screening in drug discovery.